HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hugo R Arias Selected Research

(S)- (1- azabicyclo(2.2.2)oct- 3- yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl ester

5/2010Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hugo R Arias Research Topics

Disease

2Pain (Aches)
11/2015 - 05/2010
2Alzheimer Disease (Alzheimer's Disease)
05/2009 - 12/2005
1Neuralgia (Stump Neuralgia)
11/2015
1Dementia (Dementias)
05/2010
1Neoplasms (Cancer)
07/2009

Drug/Important Bio-Agent (IBA)

1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2015
1CarrageenanIBA
11/2015
1Acetic Acid (Vinegar)FDA LinkGeneric
11/2015
1Freund's AdjuvantIBA
11/2015
1(S)- (1- azabicyclo(2.2.2)oct- 3- yl)carbamic acid (S)-1-(2-fluorophenyl) ethyl esterIBA
05/2010
1Cholinergic AgonistsIBA
07/2009
1NicotineFDA Link
07/2009
1Cholinergic Antagonists (Anticholinergics)IBA
07/2009
1alpha7 nicotinic acetylcholine receptorIBA
05/2009
1Ion Channels (Ion Channel)IBA
05/2009
1anabaseineIBA
12/2005